Wall Street stocks began the week heading north, with the S&P 500 and the Nasdaq Composite hitting new record highs, as investors cheered prospects of a new covid-19 treatment. The 30-stock Dow Jones index wiped off losses and turned positive for the year last week. Market sentiment was driven by news of the US FDA
US stocks started the week on a positive note with Amazon and Tesla leading the rally, pushing the Nasdaq to another record high. Meanwhile, the S&P 500 also hit a record high, wiping out losses from the covid-19 sell-off. Sentiment was lifted by the US witnessing a slowdown in infections, while Pfizer and BioNTech expressed
US stocks remained volatile last week, with investors growing increasingly concerned about the deadlock between the Congress and the White House over the new covid-19 rescue package. Although President Donald Trump signed orders last week to extend provide some relief, the legal status of these orders is still in question. Market sentiment was also hit
US stocks opened sharply higher last week despite a stalemate in talks on the new government stimulus package intended to support workers amid the coronavirus-induced economic recession. Markets were encouraged by an upbeat manufacturing report, which took the manufacturing PMI to 54.2 in July. Later in the week, the NFP report showed that the US
US stocks opened the week higher after closing the previous week on a negative note. as investors braced for the busiest week of earnings, while keeping an eye on discussing around the covid-19 rescue program. Positive news regarding progress on the coronavirus vaccine front also boosted market sentiment, with Moderna reporting the commencement of Phase
